The landscape of tumor treatment is constantly evolving, with a growing focus on identifying novel therapeutic targets for drug synthesis. Traditional therapies often attack rapidly dividing cells, leading to significant side effects. However, the emergence of sophisticated genomic profiling techniques has transformed our understanding of cancer bi